• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人乳头瘤病毒 16 型 E7 的保守区 3 有助于视网膜母细胞瘤肿瘤抑制因子的失调。

Conserved region 3 of human papillomavirus 16 E7 contributes to deregulation of the retinoblastoma tumor suppressor.

机构信息

Department of Microbiology and Immunology, Western University, London, Ontario, Canada.

出版信息

J Virol. 2012 Dec;86(24):13313-23. doi: 10.1128/JVI.01637-12. Epub 2012 Sep 26.

DOI:10.1128/JVI.01637-12
PMID:23015707
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3503127/
Abstract

The human papillomavirus (HPV) E7 oncoprotein binds cellular factors, preventing or retargeting their function and thereby making the infected cell conducive for viral replication. A key target of E7 is the product of the retinoblastoma susceptibility locus (pRb). This interaction results in the release of E2F transcription factors and drives the host cell into the S phase of the cell cycle. E7 binds pRb via a high-affinity binding site in conserved region 2 (CR2) and also targets a portion of cellular pRb for degradation via the proteasome. Evidence suggests that a secondary binding site exists in CR3, and that this interaction influences pRb deregulation. Additionally, evidence suggests that CR3 also participates in the degradation of pRb. We have systematically analyzed the molecular mechanisms by which CR3 contributes to deregulation of the pRb pathway by utilizing a comprehensive series of mutations in residues predicted to be exposed on the surface of HPV16 E7 CR3. Despite differences in the ability to interact with cullin 2, all CR3 mutants degrade pRb comparably to wild-type E7. We identified two specific patches of residues on the surface of CR3 that contribute to pRb binding independently of the high-affinity CR2 binding site. Mutants within CR3 that affect pRb binding are less effective than the wild-type E7 in overcoming pRb-induced cell cycle arrest. This demonstrates that the interaction between HPV16 E7 CR3 and pRb is functionally important for alteration of the cell cycle.

摘要

人乳头瘤病毒(HPV)E7 癌蛋白结合细胞因子,阻止或重新靶向其功能,从而使受感染的细胞有利于病毒复制。E7 的一个关键靶标是视网膜母细胞瘤易感基因座(pRb)的产物。这种相互作用导致 E2F 转录因子的释放,并促使宿主细胞进入细胞周期的 S 期。E7 通过保守区域 2(CR2)中的高亲和力结合位点与 pRb 结合,并且还通过蛋白酶体靶向一部分细胞 pRb 进行降解。有证据表明 CR3 中存在第二个结合位点,并且这种相互作用影响 pRb 的失调。此外,有证据表明 CR3 还参与 pRb 的降解。我们通过利用预测在 HPV16 E7 CR3 表面暴露的残基的综合系列突变,系统地分析了 CR3 对 pRb 途径失调的分子机制。尽管与 cullin 2 相互作用的能力存在差异,但所有 CR3 突变体与野生型 E7 相比降解 pRb 的能力相当。我们确定了 CR3 表面上两个独立于高亲和力 CR2 结合位点的特定残基斑块,这些残基斑块有助于 pRb 结合。影响 pRb 结合的 CR3 突变体比野生型 E7 更有效地克服 pRb 诱导的细胞周期阻滞。这表明 HPV16 E7 CR3 与 pRb 之间的相互作用对于改变细胞周期具有功能重要性。

相似文献

1
Conserved region 3 of human papillomavirus 16 E7 contributes to deregulation of the retinoblastoma tumor suppressor.人乳头瘤病毒 16 型 E7 的保守区 3 有助于视网膜母细胞瘤肿瘤抑制因子的失调。
J Virol. 2012 Dec;86(24):13313-23. doi: 10.1128/JVI.01637-12. Epub 2012 Sep 26.
2
Identification of a novel retinoblastoma gene product binding site on human papillomavirus type 16 E7 protein.人乳头瘤病毒16型E7蛋白上新的视网膜母细胞瘤基因产物结合位点的鉴定。
J Biol Chem. 1994 Mar 4;269(9):6842-50.
3
Structure of the human Papillomavirus E7 oncoprotein and its mechanism for inactivation of the retinoblastoma tumor suppressor.人乳头瘤病毒E7癌蛋白的结构及其使视网膜母细胞瘤肿瘤抑制因子失活的机制。
J Biol Chem. 2006 Jan 6;281(1):578-86. doi: 10.1074/jbc.M508455200. Epub 2005 Oct 24.
4
The high-risk HPV16 E7 oncoprotein mediates interaction between the transcriptional coactivator CBP and the retinoblastoma protein pRb.高危型人乳头瘤病毒16 E7癌蛋白介导转录共激活因子CBP与视网膜母细胞瘤蛋白pRb之间的相互作用。
J Mol Biol. 2014 Dec 12;426(24):4030-4048. doi: 10.1016/j.jmb.2014.10.021. Epub 2014 Nov 1.
5
The canine papillomavirus and gamma HPV E7 proteins use an alternative domain to bind and destabilize the retinoblastoma protein.犬乳头瘤病毒和γ HPV E7 蛋白使用替代结构域结合并破坏视网膜母细胞瘤蛋白。
PLoS Pathog. 2010 Sep 2;6(9):e1001089. doi: 10.1371/journal.ppat.1001089.
6
Mutagenesis of the pRB pocket reveals that cell cycle arrest functions are separable from binding to viral oncoproteins.pRB口袋区域的诱变表明,细胞周期阻滞功能与结合病毒癌蛋白的功能是可分离的。
Mol Cell Biol. 2000 May;20(10):3715-27. doi: 10.1128/MCB.20.10.3715-3727.2000.
7
The human papillomavirus E7 oncoprotein and the cellular transcription factor E2F bind to separate sites on the retinoblastoma tumor suppressor protein.人乳头瘤病毒E7癌蛋白与细胞转录因子E2F分别结合于视网膜母细胞瘤肿瘤抑制蛋白的不同位点。
J Virol. 1993 Apr;67(4):2402-7. doi: 10.1128/JVI.67.4.2402-2407.1993.
8
Human papillomavirus type 45 E7 is a transforming protein inducing retinoblastoma protein degradation and anchorage-independent cell cycle progression.人乳头瘤病毒45型E7是一种诱导视网膜母细胞瘤蛋白降解和非贴壁依赖性细胞周期进程的转化蛋白。
Virology. 2008 Sep 15;379(1):20-9. doi: 10.1016/j.virol.2008.06.004. Epub 2008 Jul 22.
9
Human papillomavirus type 16 E7 oncoprotein associates with the cullin 2 ubiquitin ligase complex, which contributes to degradation of the retinoblastoma tumor suppressor.人乳头瘤病毒16型E7癌蛋白与cullin 2泛素连接酶复合物相关联,这有助于视网膜母细胞瘤肿瘤抑制因子的降解。
J Virol. 2007 Sep;81(18):9737-47. doi: 10.1128/JVI.00881-07. Epub 2007 Jul 3.
10
The CXXC Zn binding motifs of the human papillomavirus type 16 E7 oncoprotein are not required for its in vitro transforming activity in rodent cells.人乳头瘤病毒16型E7癌蛋白的CXXC锌结合基序对其在啮齿动物细胞中的体外转化活性并非必需。
Oncogene. 1998 Feb 26;16(8):1085-9. doi: 10.1038/sj.onc.1201617.

引用本文的文献

1
Ubiquitin and ubiquitin-like proteins in HPV-driven carcinogenesis.人乳头瘤病毒驱动的致癌作用中的泛素和类泛素蛋白
Oncogene. 2025 Mar;44(11):713-723. doi: 10.1038/s41388-025-03310-6. Epub 2025 Feb 26.
2
The effect of phosphorylation efficiency on the oncogenic properties of the protein E7 from high-risk HPV.磷酸化效率对高危型 HPV 蛋白 E7 致癌特性的影响。
Virus Res. 2024 Oct;348:199446. doi: 10.1016/j.virusres.2024.199446. Epub 2024 Aug 14.
3
Structural analysis of PTPN21 reveals a dominant-negative effect of the FERM domain on its phosphatase activity.结构分析揭示了 PTPN21 的 FERM 结构域对其磷酸酶活性的显性抑制效应。
Sci Adv. 2024 Mar;10(9):eadi7404. doi: 10.1126/sciadv.adi7404. Epub 2024 Feb 28.
4
The Value of CXCL1, CXCL2, CXCL3, and CXCL8 as Potential Prognosis Markers in Cervical Cancer: Evidence of E6/E7 from HPV16 and 18 in Chemokines Regulation.CXCL1、CXCL2、CXCL3和CXCL8作为宫颈癌潜在预后标志物的价值:人乳头瘤病毒16型和18型E6/E7在趋化因子调控中的证据
Biomedicines. 2023 Sep 28;11(10):2655. doi: 10.3390/biomedicines11102655.
5
Friend or Foe: Regulation, Downstream Effectors of RRAD in Cancer.敌友难分:RRAD 在癌症中的调控及其下游效应子。
Biomolecules. 2023 Mar 5;13(3):477. doi: 10.3390/biom13030477.
6
ZER1 Contributes to the Carcinogenic Activity of High-Risk HPV E7 Proteins.ZER1 有助于高危型 HPV E7 蛋白的致癌活性。
mBio. 2022 Dec 20;13(6):e0203322. doi: 10.1128/mbio.02033-22. Epub 2022 Nov 8.
7
Repression of Memo1, a Novel Target of Human Papillomavirus Type 16 E7, Increases Cell Proliferation in Cervical Cancer Cells.抑制 HPV16 E7 的新型靶标 Memo1 可促进宫颈癌细胞增殖。
J Virol. 2022 Oct 26;96(20):e0122922. doi: 10.1128/jvi.01229-22. Epub 2022 Oct 5.
8
The Not-So-Good, the Bad and the Ugly: HPV E5, E6 and E7 Oncoproteins in the Orchestration of Carcinogenesis.不那么好、坏和丑:HPV E5、E6 和 E7 致癌蛋白在致癌作用中的协同作用。
Viruses. 2021 Sep 22;13(10):1892. doi: 10.3390/v13101892.
9
The Mus musculus Papillomavirus Type 1 E7 Protein Binds to the Retinoblastoma Tumor Suppressor: Implications for Viral Pathogenesis.小鼠多瘤病毒 1 型 E7 蛋白与视网膜母细胞瘤肿瘤抑制基因结合:对病毒发病机制的影响。
mBio. 2021 Aug 31;12(4):e0227721. doi: 10.1128/mBio.02277-21.
10
Molecular Analysis of the Interaction between Human PTPN21 and the Oncoprotein E7 from Human Papillomavirus Genotype 18.人乳头瘤病毒 18 型致癌蛋白 E7 与人 PTPN21 相互作用的分子分析
Mol Cells. 2021 Jan 31;44(1):26-37. doi: 10.14348/molcells.2020.0169.

本文引用的文献

1
Systematic identification of interactions between host cell proteins and E7 oncoproteins from diverse human papillomaviruses.系统鉴定不同型别人类乳头瘤病毒宿主细胞蛋白与 E7 癌蛋白的相互作用。
Proc Natl Acad Sci U S A. 2012 Jan 31;109(5):E260-7. doi: 10.1073/pnas.1116776109. Epub 2012 Jan 9.
2
Systematic analysis of the amino acid residues of human papillomavirus type 16 E7 conserved region 3 involved in dimerization and transformation.系统分析人乳头瘤病毒 16 型 E7 保守区 3 中参与二聚化和转化的氨基酸残基。
J Virol. 2011 Oct;85(19):10048-57. doi: 10.1128/JVI.00643-11. Epub 2011 Jul 20.
3
The E7 open reading frame acts in cis and in trans to mediate differentiation-dependent activities in the human papillomavirus type 16 life cycle.E7 开放阅读框在顺式和反式作用中介导人乳头瘤病毒 16 型生命周期中分化依赖的活性。
J Virol. 2011 Sep;85(17):8852-62. doi: 10.1128/JVI.00664-11. Epub 2011 Jun 22.
4
Long term protection against cervical infection with the human papillomavirus: review of currently available vaccines.人乳头瘤病毒宫颈感染的长期预防:现有疫苗综述
Hum Vaccin. 2011 Feb;7(2):161-9. doi: 10.4161/hv.7.2.13690. Epub 2011 Feb 1.
5
Human papillomavirus E7 enhances hypoxia-inducible factor 1-mediated transcription by inhibiting binding of histone deacetylases.人乳头瘤病毒 E7 通过抑制组蛋白去乙酰化酶的结合来增强低氧诱导因子 1 介导的转录。
Cancer Res. 2011 Feb 1;71(3):1187-95. doi: 10.1158/0008-5472.CAN-10-2626. Epub 2010 Dec 8.
6
The biochemical basis of CDK phosphorylation-independent regulation of E2F1 by the retinoblastoma protein.视网膜母细胞瘤蛋白对 E2F1 的 CDK 磷酸化非依赖性调节的生化基础。
Biochem J. 2011 Mar 1;434(2):297-308. doi: 10.1042/BJ20101210.
7
The E4orf6/E1B55K E3 ubiquitin ligase complexes of human adenoviruses exhibit heterogeneity in composition and substrate specificity.人腺病毒 E4orf6/E1B55K E3 泛素连接酶复合物在组成和底物特异性上表现出异质性。
J Virol. 2011 Jan;85(2):765-75. doi: 10.1128/JVI.01890-10. Epub 2010 Nov 10.
8
FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP).美国食品药品监督管理局批准二价人乳头瘤病毒疫苗(HPV2,佳达修)用于女性,并更新了免疫实践咨询委员会(ACIP)的 HPV 疫苗接种建议。
MMWR Morb Mortal Wkly Rep. 2010 May 28;59(20):626-9.
9
Targeting mechanism of the retinoblastoma tumor suppressor by a prototypical viral oncoprotein. Structural modularity, intrinsic disorder and phosphorylation of human papillomavirus E7.典型病毒癌蛋白对视网膜母细胞瘤肿瘤抑制因子的靶向作用。人乳头瘤病毒 E7 的结构模块性、固有无序性和磷酸化。
FEBS J. 2010 Feb;277(4):973-88. doi: 10.1111/j.1742-4658.2009.07540.x. Epub 2010 Jan 20.
10
pRb, a local chromatin organizer with global possibilities.视网膜母细胞瘤蛋白(pRb),一种具有全局作用可能性的局部染色质组织者。
Chromosoma. 2010 Feb;119(1):1-11. doi: 10.1007/s00412-009-0238-0. Epub 2009 Aug 28.